Precision in Healing
for Tomorrow's Health
Engineered radiopharmaceuticals that deliver lethal radiation with surgical accuracy — destroying cancer cells while preserving healthy tissue.
The Century-Old Radiation Dilemma
Powerful enough to kill tumors. Too dangerous for healthy cells. Until now.
Therapies That Act Like
Smart Missiles
Our proprietary platform combines advanced ligand design, optimized chelators, and therapeutic isotopes to create targeted radiopharmaceuticals that deliver lethal radiation only to cancer cells.
One dose. One target. Maximum impact.
Our Precision Technology Stack
Every component engineered for unmatched specificity, stability, and therapeutic power — from ligand to isotope.
Hyper-Selective Ligands
Bind exclusively to tumor-specific receptors with sub-nanomolar affinity for zero off-target effects.
Optimized Chelators
Lock radioisotopes with extreme stability — no leakage, no damage to healthy organs.
Alpha & Beta Emitters
High-LET alpha particles for DNA destruction; beta for deeper tissue penetration.
Biodistribution Control
Rapid clearance from healthy organs, prolonged retention in tumors for maximum efficacy.
Life-Changing Clinical Outcomes
Precision isn't theoretical — it's measurable in lives saved and quality preserved.
Tumor Targeting Accuracy
Reduction in Side Effects
Single-Dose Protocol
Pediatric Applications
Development Pipeline
From discovery to clinic — advancing multiple candidates across solid tumors and rare cancers.
AYT-101
Neuroendocrine Tumors
Phase II
AYT-204
Pediatric Sarcoma
Phase I
AYT-307
Prostate Cancer
Preclinical
AYT-410
Brain Tumors
Discovery
The Future of Cancer Therapy Is Here
Join us in redefining what's possible in oncology. Precision. Power. Hope.
Partner With Us